For decades, people living with type 1 diabetes have carried a quiet fear into their most intimate moments — the worry that closeness might trigger a dangerous drop in blood sugar. Researchers at the Medical University of Warsaw have now done what no one had done before: they measured what actually happens. Tracking 110 sexual encounters across 12 adults over three months, they found no clinically significant hypoglycemia, offering science where only anxiety had lived before. The findings arrive not merely as medical data, but as a small restoration of freedom — a reminder that fear, when left
Study: Sexual Activity Safe for Type 1 Diabetes Patients, CGM Data Shows
Fear of hypoglycemia during sexual activity has adversely affected intimacy and quality of life for people with type 1 diabetes.
Fear of hypoglycemia can lead people to avoid intimacy altogether
Mark
So the headline is basically "sex doesn't cause dangerous low blood sugar in type 1 diabetes." But the study is only 12 people. How much weight does that actually carry?
Mimi
It's small, yes, but it's the first time anyone has measured this objectively with real glucose data. Before this, everything was self-reported fear and worry. Twelve people over three months gave them 110 actual sexual events to analyze. That's real data, not anecdotes.
Luke
But 12 people is still 12 people. We don't know if they're representative. Were they younger, healthier, more stable? The paper doesn't say much about selection bias. And the median age is 36—what about teenagers, who might have different physiology?
Mimi
Fair point. But the finding is consistent: zero clinically significant hypoglycemia across all 110 events. That's a strong signal, even in a small group.
Mark
The blood sugar went up in 42 percent of cases and down in 58 percent. So it's not predictable. How does that help someone manage their fear?
Mimi
Because it shows the fear of catastrophic low blood sugar isn't borne out by the data. Yes, it's variable. But variable doesn't mean dangerous. And the researchers found patterns—nighttime sex did lower glucose more, higher starting glucose led to bigger drops. That's actionable information for counseling.
Luke
But here's the thing: all 12 people in this study were using CGM. They had real-time data and alerts. The researchers themselves say that people without CGM have no idea what's happening to their blood sugar during sex. So this study really only applies to the minority of type 1 diabetics who have access to and use CGM technology.
Mimi
That's the honest limitation, yes. And it's a big one. But it's also why the researchers are calling for wider CGM access. The technology exists to make this safe and knowable.
Mark
So what happens next? Does this change how doctors talk to their patients?
Mimi
That's the hope. Right now, almost no one asks about sex. Patients are embarrassed, doctors don't bring it up. This gives clinicians actual evidence to say: "This is safe. Your fear is understandable, but the data shows you don't need to avoid intimacy." That's powerful.
Luke
If the study gets replicated in a larger, more diverse group and holds up, then yes. One small study is a conversation starter, not a clinical guideline.
Le Pouls
- One in three young adults with type 1 diabetes has reported anxiety about hypoglycemia during sex — a fear that, for some, has quietly eroded intimacy and quality of life.
- Until this study, no physiological data existed: the entire clinical picture was built on patient surveys alone, leaving a dangerous gap between lived experience and medical understanding.
- Continuous glucose monitors tracked 110 sexual events over three months, and not a single one produced clinically significant low blood sugar — even during nighttime activity, when hypoglycemia is hardest to detect.
- Blood sugar responses proved complex and bidirectional — dropping after 58% of encounters and rising after 42% — shaped by starting glucose levels, BMI, and time of day, meaning no single rule fits every person or every night.
- The findings are bounded by an important limit: they apply only to the roughly 60% of type 1 diabetes patients who use continuous glucose monitors — for the rest, the uncertainty, and the fear, remain real.
- Presented at the European Association for the Study of Diabetes annual meeting in Milan, the research may finally give clinicians the language to open a conversation that almost never happens in the clinic.
For decades, people living with type 1 diabetes have carried a quiet fear into their most intimate moments — the worry that closeness might trigger a dangerous drop in blood sugar. Researchers at the Medical University of Warsaw have now done what no one had done before: they measured what actually happens. Tracking 110 sexual encounters across 12 adults over three months, they found no clinically significant hypoglycemia, offering science where only anxiety had lived before. The findings arrive not merely as medical data, but as a small restoration of freedom — a reminder that fear, when left unmeasured, can cost us more than the risk itself.
For people with type 1 diabetes, the fear of a sudden blood sugar crash during sex has long been a silent barrier to intimacy. A 2017 survey found roughly one in three young adults with the condition reported anxiety about hypoglycemia during sexual activity — yet no one had ever actually measured what happens physiologically. The worry was documented; the biology was not.
Dr. Dominica Orłowska and colleagues at the Medical University of Warsaw set out to close that gap. They equipped 12 adults — seven women and five men, median age 36 — with continuous glucose monitoring devices and asked them to log sexual activity over three months. Six used insulin injections; six used pumps. Across the study period, 110 encounters were recorded and analyzed, examining glucose data from two hours before to six hours after each event.
The headline finding was reassuring: no clinically significant hypoglycemia occurred in any of the 110 events. But the picture was more layered than a simple verdict of safety. Blood sugar moved in both directions — falling after 58% of encounters and rising after 42%. The same person could experience both patterns at different times. What shaped the outcome was context: the glucose level before sex began, the person's BMI, and whether the activity happened during the day or at night. Nighttime sex produced a statistically significant glucose drop; daytime sex produced almost none.
The stakes are particular to this condition. Unlike running or cycling, sex is rarely planned — it happens spontaneously, often at night, precisely when undetected hypoglycemia is most dangerous. And it is almost never discussed in clinical settings. Patients receive guidance on exercise; almost no one asks about sex. The fear grows in silence, and for some, becomes reason enough to avoid intimacy entirely.
Orłowska frames the paradox directly: sex life is central to quality of life, and fear of hypoglycemia can lead people to withdraw from it. The data suggest that fear may be disproportionate to actual risk — at least for those using CGM technology. That caveat matters. Roughly 40% of people with type 1 diabetes do not use continuous monitors and have no real-time way to know whether their glucose is falling. For them, the uncertainty — and the fear it feeds — remains genuinely unresolved. The findings will be presented at the European Association for the Study of Diabetes annual meeting in Milan at the end of September.
For people living with type 1 diabetes, the fear of a sudden drop in blood sugar during sex has become a quiet barrier to intimacy. The worry is not unfounded—a 2017 survey of 53 young adults with the condition found that roughly one in three reported anxiety about hypoglycemia during sexual activity. But until now, no one had actually measured what happens to blood glucose during sex. All the evidence came from what patients said in interviews and questionnaires. The lived experience was documented; the physiology was not.
Dr. Dominica Orłowska and colleagues at the Medical University of Warsaw decided to change that. They equipped 12 adults with type 1 diabetes—seven women and five men, with a median age of 36—with continuous glucose monitoring devices (either FreeStyle Libre 2 or Guardian 4) and asked them to log their sexual activity over three months. Six participants used multiple daily insulin injections; six used insulin pumps, including two with automated insulin delivery systems. The researchers then examined the glucose data from two hours before to six hours after each recorded event. Over the study period, 110 sexual encounters were logged and analyzed.
What they found was reassuring: no clinically significant hypoglycemia occurred in any of the events. But the picture was more nuanced than a simple "sex is safe" conclusion. Blood sugar responses went in both directions. In 58 percent of the 110 events—64 occasions—glucose levels dropped after sex, declining on average from 180 to 132 milligrams per deciliter. In the remaining 42 percent of events, glucose rose, climbing from 122 to 164 milligrams per deciliter. The same person experienced both patterns at different times. What mattered was context: the glucose level before sex began, the person's body mass index, and whether the activity happened during the day or at night.
Nighttime sex showed a statistically significant drop in glucose, falling from 165 to 147 milligrams per deciliter across 66 events. Daytime sex, recorded 44 times, produced essentially no change—glucose stayed flat at around 143 to 144 milligrams per deciliter. People with a BMI of 25 or higher saw a larger glucose decrease after sex than those with a lower BMI. The starting glucose level mattered too: those who began sex with higher blood sugar experienced a greater drop, while those starting lower saw a smaller rise.
The findings matter because sexual activity occupies a peculiar place in diabetes management. Unlike exercise, which can be planned—insulin doses reduced, food eaten beforehand, activity modes activated on pumps—sex is typically spontaneous. It often occurs in the evening or at night, the very window when the risk of severe, unrecognized hypoglycemia is highest. And it is almost never discussed in the clinic. Patients will talk to their doctors about running or cycling and receive concrete guidance. Almost no one asks about sex. The fear festers in silence, and for some people, that fear becomes reason enough to avoid intimacy altogether.
Orłowska notes the paradox plainly: "Sex life is central to quality of life, and fear of hypoglycaemia can lead people to avoid intimacy." The research suggests that fear may be disproportionate to actual risk. None of the participants experienced clinically significant low blood sugar, even during nighttime activity, even though nighttime is when hypoglycemia is hardest to detect and most dangerous. The study will be presented at the Annual Meeting of The European Association for the Study of Diabetes in Milan from September 28 to October 2.
There is one important caveat. All 12 participants in this study used continuous glucose monitoring devices. Those devices provide real-time data and alerts. For the roughly 40 percent of people with type 1 diabetes who do not use CGM, the picture is different. They have no objective way to know whether their blood sugar is dropping during sex—or during any other activity. For them, the fear remains not just psychological but genuinely grounded in uncertainty. The researchers are clear on this point: in an ideal world, every person with type 1 diabetes would have access to CGM technology. Until that happens, the gap between what is safe and what feels safe will persist for many.
Citations marquantes
Sex life is central to quality of life, and fear of hypoglycaemia can lead people to avoid intimacy.— Dr. Dominica Orłowska, Medical University of Warsaw
In an ideal world, every person with type 1 diabetes should be using CGM. Those who do not may have no idea whether they are experiencing hypoglycaemia during sex—or, in fact, any setting.— Study authors
Envie de l'histoire complète ?
Lire l'original sur Mirage News ↗
Health & Medicine